logo
搜索
菜单

pharmacolo的搜索结果

当前1/5页
排序: 最近更新
4.13: Restless Leg Syndrome and Night Terrors 01:27 min
4.13: Restless Leg Syndrome and Night Terrors
17.3: Drug Toxicity: Dose-Dependent Reactions 01:24 min
17.3: Drug Toxicity: Dose-Dependent Reactions
17.1: Drug Toxicity: Overview 01:00 min
17.1: Drug Toxicity: Overview
15.14: Pharmacodynamic Models: Direct Effect Model and Indirect Response Model 01:29 min
15.14: Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
15.13: Pharmacodynamic Models: Additive and Proportional Drug Effect Model 01:09 min
15.13: Pharmacodynamic Models: Additive and Proportional Drug Effect Model
15.12: Pharmacodynamic Models: Logarithmic Concentration–Effect Model 01:15 min
15.12: Pharmacodynamic Models: Logarithmic Concentration–Effect Model
15.11: Pharmacodynamic Models: Linear Concentration–Effect Model 01:15 min
15.11: Pharmacodynamic Models: Linear Concentration–Effect Model
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components 01:14 min
15.7: Pharmacokinetic–Pharmacodynamic Relationship: Model Components
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems 01:24 min
15.6: Pharmacokinetic–Pharmacodynamic Relationship: Problems
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect 01:28 min
15.2: Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
13.1: Drug Dosing: Infants and Children 01:29 min
13.1: Drug Dosing: Infants and Children
12.18: Pharmacokinetics: Drug–Food and Drug–Viral Interactions 01:26 min
12.18: Pharmacokinetics: Drug–Food and Drug–Viral Interactions
12.17: Pharmacokinetics: Drug–Drug Interactions 01:25 min
12.17: Pharmacokinetics: Drug–Drug Interactions
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses 01:25 min
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses 01:25 min
12.11: Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
9.12: Equivalence: In Vitro and In Vivo Bioequivalence 01:17 min
9.12: Equivalence: In Vitro and In Vivo Bioequivalence
9.8: Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems 01:22 min
9.8: Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
9.7: Measurement of Bioavailability: Pharmacodynamic Methods 01:20 min
9.7: Measurement of Bioavailability: Pharmacodynamic Methods
The ex vivo Isolated Skeletal Microvessel Preparation for Investigation of Vascular Reactivity 10.3791/3674-v 07:00 min
The ex vivo Isolated Skeletal Microvessel Preparation for Investigation of Vascular Reactivity
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation 10.3791/3671-v
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
返回顶部